Research Article

RTA-408 Protects Kidney from Ischemia-Reperfusion Injury in Mice via Activating Nrf2 and Downstream GSH Biosynthesis Gene

Figure 8

RTA-408 did not confer protection against renal ischemia-reperfusion injury in Nrf2−/− mice. RTA-408 (100 μg/kg bw) or vehicle (0.1% DMSO) was administered intraperitoneally 24 h before surgery. All 8-week-old male Nrf2−/− mice underwent contralateral nephrectomy and 30 min unilateral ischemia followed by reperfusion for up to 24 h. Nrf2−/− mice receiving RTA-408 () did not show improvement in renal function (a), ATN score (c, d), ROS production (e, f), and Nrf2 downstream gene expression (b) at 24 h reperfusion when compared with Nrf2−/− mice receiving vehicle (). Magnification 400x; scale bar 50 μm.
(a)
(b)
(c)
(d)
(e)
(f)